trainers become familiar with the assessments and other aspects of the ISCP.
In recognition of the need to continue with the programme of improvements, the ISCP has organized a trainees feedback day, to take place on 11 September. A wide and inclusive range of trainees has been invited to join the ISCP team, and work collaboratively towards developing the next version (version 6) of the ISCP which will be launched by the end of 2009. We can look forward to further developments and improvements in the near future as the ISCP goes into partnership with OCAP, and good practice will be shared between the two programmes.
Pereira and Dean are, however, quite right to draw our attention to the Eraut Report 2 into the implementation phase of the ISCP, but should ensure that they draw the right conclusions from it and report them accurately. The report actually concluded that the potential benefits of an improved system for surgical training were in danger of being negated by the many other changes taking place in the training environment and the NHS. The JCST is currently undertaking a wide-ranging consultation in order to identify practical methods to restore high quality surgical training. During these challenging times, it is important to resist the temptation to 'throw out the baby with the bathwater'. Instead we would like to reassure the authors as well as all users of ISCP that 'constructive [our italics] criticism by trainees and trainers alike will be heeded by the developers' and that the 'versatility and usability of the ISCP will continue to improve'.
The distinction between gross negligence and recklessness in English criminal law
Merry states that 'in practice the distinction between gross negligence and recklessness may be very subtle'.
1 I wonder if his discussion of both the law and the relevant medical errors is outdated.
Recklessness in English criminal law is advertent, and as Merry states, requires the conscious choice to take an unjustified risk. Criminal negligence is variously defined, but is usually regarded as not requiring advertence. One textbook definition is '. the inadvertent taking of an unjustifiable risk'. 2 Historically, confusion has arisen from gross negligence manslaughter being sometimes known as reckless manslaughter. This should no longer be the case. The current leading cases, which Merry does not cite, are Adomako 3 and Misra. 4 Following these cases, a conviction for gross negligence manslaughter requires the existence of a duty of care, breach of that duty resulting in death and a risk of death which would be obvious to a reasonable prudent person. Additionally, the defendant's conduct must have fallen so far below the standard of a reasonable practitioner as to be grossly negligent in the view of the jury, and thereby warranting a criminal conviction for manslaughter.
Although there is overlap, reckless manslaughter has a distinctly different meaning.
Similarly, Merry's discussion of intrathecal vincristine administration would be enhanced by discussion of the incident at Nottingham in 2001. A junior doctor was prosecuted for gross negligence manslaughter, and pleaded guilty. However, an external inquiry identified over 50 other contributory factors to the fatal event.
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I hope this additional material may prove interesting and informative to JRSM readers. Data mining can support quality assurance Doctors Hockey and Marshall's essay on the need to train doctors in quality improvement, citing its successful use by manufacturers and US doctors 1 is timely as it is now nearly a century since the first suggestions that hospitals might use industrial methods of management and surgeons provide formal quality assurance. In the meantime manufacturers have evolved into world-class companies, able to meet global demand, by paring processes down to provide goods of a narrow albeit protean quality, ones which satisfy customer requirements at an acceptable price. Their lean processes are rigidly defined and incorporated into comprehensive systems of Total Quality Management (TQM) so no activity, be it lean manufacturing or continuous improvement, functions in isolation. But despite the opinion that TQM concepts apply equally to manufacturing and service industries no company providing personal healthcare has succeeded in joining the world-class paragons and there is a corresponding absence of TQM at unit level in healthcare. In the case of surgery, a service in some respects close to the ethos of the craft workshops which developed into factories, there are fewer than a dozen reports containing the terms 'surgery' with 'TQM' in Pubmed. Of these only one used outcome of introducing TQM as its topic (it found little effect). 2 This paucity is in contrast with an abundance of publications about clinically-driven surgical quality. The difference in activity in a lively discipline with an obvious commitment to quality is likely to reflect difficulty of extending a linear model into an environment which is complex and adaptive. 3 As this healthcare environment is also knowledge-based and creates vast amounts of data doctors with an interest in quality assurance should familiarize themselves with data mining for patterns of care as an aid to discovering better processes 4 and meeting inequalities in care. 
Peter Gooderham

Research governance approval delays studies
In the May 2009 edition of JRSM your headline article was 'Research governance delays for a non-interventional study' a sentiment which many researchers may share. 1 The authors put the reasons for delay clearly in the arms of research and development departments (RDD) where significant variation in processes leads to variation in delay. While we do not defend the over-bureaucratic system for research approval in the UK our findings suggest that the reason for delay must be shared among those involved in the study. In 2006 we published an article which examined the delays in a similar multicentre observational study which involved 178 sites across the UK, of which 159 were hospital trusts. 2 We examined the reason for delay at all sites taking more than 60 days for approval (i.e. more than the legally specified time currently required for ethics committee review). 3 We found that the mean approval time was 82 days with a range of 0-259 days, thus supporting the wide variation identified by Mallick and O'Callaghan. In our analysis more than half the hospital sites took longer than 60 days (n=86, mean 126 days) to obtain local approval. We examined the source of the delay and found that of those cases taking more than 60 days, 25 (29%) were delayed at the RDD while 22 (26%) were delayed while awaiting investigators to respond to queries and 11 (13%) delayed at the trust level awaiting sign off. The remaining 28 had mixed reasons for delay beyond 60 days.
We therefore support the call for an improved approval system but would suggest that all parties involved in the approval process must be prepared to support change and act in a timely manner. I was surprised to read in the JRSM, of all places, a gratuitous reference to VS Naipaul's 'racism' from Jim Thornton, 1 who has just read a new biography of the great writer. 2 The biographer, Patrick French, indeed pulls no punches (like Naipaul himself), yet he does not call his subject a racist or show him to be one. If the charge is levelled with tiresome regularity by certain PC critics, this is because Naipaul has not fallen for the fallacy of 'the superior virtue of the oppressed', as Bertrand Russell, not a racist either, once called it. To read Naipaul's works with both eyes open is to understand that they are one long and masterful plea for human dignity and freedom. His knighthood and Nobel Prize are an honour, not just to him, but to Britain and the world. 
Maynard made me laugh
Alan Maynard's statement that the Irish have moved to offer their population 'free' prescriptions 1 made me laugh. Alas, he couldn't be more wrong. Six months ago, the financial shambles, brought about by banksters and weak regulators, caused the Irish government to remove free medical attention, including free prescriptions, from those lucky enough to have qualified for a 'medical card', but unfortunate to have a weekly income over V700. However, no-one has to pay more than V100 for medications in any month.
It's impossible to say how long this situation will last. Probably for a long time, since we're expecting even more swingeing cuts in social services in the coming months.
